People
Joined BGF in 2023, focusing on early-stage science and technology investments. Previously worked at Wren Therapeutics in neurodegeneration, OMBU and BCG. Has a Cambridge PhD and serves on the Phlux board.
Roles
BGFPortfolio Partner — Early Stage
Current